A Porsche for patient accrual

Area of Science:

• Oncology
• Clinical Trials
• Medical Ethics

Background:

• Patient accrual is critical for cancer research.
• Incentives are sometimes used to encourage patient enrollment in clinical trials.
• The ethical implications of financial incentives require careful consideration.

Purpose of the Study:

• To evaluate the ethical implications of offering substantial financial incentives for patient accrual in oncology clinical trials.
• To explore the potential impact of such incentives on public perception and scientific integrity.

Main Methods:

• The study discusses a specific instance of a lottery prize for patient accrual in a Southwest Oncology Group prostate cancer protocol.
• It analyzes the ethical considerations and potential consequences of this incentive structure.

Main Results:

• The incentive, while intended to boost patient enrollment, raises ethical concerns.
• Rewarding physicians with expensive prizes may create a perception of self-interest over patient welfare.
• Widespread use of such incentives could damage public confidence in clinical research.

Conclusions:

• The practice of offering expensive rewards for patient accrual in clinical trials is ethically questionable.
• Such incentives may erode public trust and potentially harm the reputation of medical research.
• The long-term negative consequences may outweigh the short-term benefits of increased patient enrollment.